Literature DB >> 33950127

Pneumocystis jirovecii pneumonia in a patient with HIV infection: complex diagnosis using Giemsa-stained bronchoalveolar lavage fluid.

Louisy Sanches Dos Santos1, Lincoln de Oliveira Sant'Anna1, Max Roberto Batista Araújo2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33950127      PMCID: PMC8083882          DOI: 10.1590/0037-8682-0150-2021

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


× No keyword cloud information.
A 54-year-old Brazilian man presented to the emergency department with cough, chest pain, high fever, and dyspnea. He had no history of sexually transmitted infections. A thoracic computed tomography scan showed ground-glass opacification areas and mediastinal lymphadenopathy. Laboratory tests revealed the following abnormalities: absolute monocyte count,80 cells/mm3; partial pressure of oxygen, 55.3 mmHg; and C-reactive protein,304.3 mg/L. Blood tests for cytomegalovirus, Chlamydia pneumoniae, Legionella pneumophila, and Mycoplasma pneumoniae and a sputum analysis for Mycobacterium tuberculosis were negative. Microscopic examination of Giemsa-stained bronchoalveolar lavage fluid (BALF) showed cysts of the atypical fungus Pneumocystis jirovecii (Figure 1), the etiological agent of pneumocystis pneumonia (PCP). Additional investigations revealed human immunodeficiency virus (HIV) infection, low CD4+T-cell count (128 cells/mm3), and increased lactate dehydrogenase levels. Antiretroviral therapy (ART) and trimethoprim/sulfamethoxazole (14 days) treatment were established. The patient was discharged 30 days post-admission.
FIGURE 1:

Giemsa staining (original magnification, ×1000) of bronchoalveolar fluid showing cyst forms of Pneumocystis jirovecii (black arrow).

PCP is a life-threatening infection that is often observed in immunocompromised individuals. Although the incidence has decreased among HIV-infected individuals due to the widespread use of ART and prophylaxis, PCP remains the most prevalent opportunistic infection among HIV-infected patients worldwide and persists as the main acquired immunodeficiency syndrome-defining infection . Due to non-specific signs and symptoms, and because P. jirovecii cannot be cultured in artificial media, the diagnosis of PCP is challenging. Methods involving DNA detection and serological biomarkers are available, but the microscopic observation of P. jirovecii in BALF is still the gold standard for PCP diagnosis , .
  2 in total

1.  Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers.

Authors:  F Esteves; S S Calé; R Badura; M G de Boer; F Maltez; E J Calderón; T J van der Reijden; E Márquez-Martín; F Antunes; O Matos
Journal:  Clin Microbiol Infect       Date:  2014-12-04       Impact factor: 8.067

2.  Pneumocystis and Pneumocystosis: first meeting of experts from Latin-American and Portuguese-speaking countries - a mini-review.

Authors:  Francisco Esteves; Francisco J Medrano; Yaxsier de Armas; Gustavo Wissmann; Enrique J Calderón; Olga Matos
Journal:  Expert Rev Anti Infect Ther       Date:  2014-03-11       Impact factor: 5.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.